Novartis takes an active role in public-policy debates affecting our business. It is our responsibility to share our perspective, scientific knowledge and technical expertise with policymakers and regulatory authorities. It is also in our interest, as a good corporate citizen, to campaign for policies and regulations that favor ethical business conduct.

Trade associations aid in both of these goals while also raising standards across our industry and helping toward best-practice exchange.

We strive for constructive partnerships with governments and other stakeholders to increase access to medicines and health information while preserving incentives for research and innovation through competitive pricing.

In our lobbying and advocacy activities – as in all other areas of our business – we are governed by the Novartis Code of Conduct and we strive for integrity, openness, transparency and consistency in our business activities.

Learn more about our commitment to responsible lobbying on our website Citizenship@Novartis